Judith-anne W. Chapman
10 Stuart St
Kingston, ON, Canada
Kingston, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Journal: Breast cancer research and treatment
Published: March 25, 2025
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2024
Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer.
Journal: Clinical breast cancer
Published: January 12, 2021
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.
Journal: Journal of the National Cancer Institute
Published: February 20, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Journal: Breast cancer research and treatment
Published: February 02, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
Journal: Journal of the National Cancer Institute
Published: October 21, 2017
Poor working conditions and work stress among Canadian sex workers.
Journal: Occupational medicine (Oxford, England)
Published: October 11, 2017
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.
Journal: Journal of the National Cancer Institute
Published: August 04, 2017
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Journal: Breast cancer research and treatment
Published: February 23, 2017
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 02, 2016
Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
Journal: Clinical breast cancer
Published: October 13, 2016
Last Updated: 09/26/2026